The long-term weight loss effect of GLP-1RAs has also been validated in a recent large-scale clinical trial, which reported a weight loss up to 20.9% after 72-week treatment of tirzepatide [22]
Tirzepatide is a newer dual GIP/GLP-1 receptor agonist with a similar low intrinsic hypoglycaemia risk when used alone
If you miss your scheduled dose entirely and remember within four days, take the missed dose as soon as possible, then resume your regular weekly schedule
Peptides that affect glucose and insulin signaling can aggravate dysglycemia or hide insulin requirements
If you cannot get a higher concentration vial, solution 1 (splitting the dose) is the safest and most practical approach
The launch of Wegovy was probably the first issue that Novo ran into, because they really just couldnt supply the market, said Evan Seigerman, a managing director and senior analyst at BMO Capital Markets (BMO)